96 related articles for article (PubMed ID: 1676332)
1. A strychnine-sensitive site is involved in dynorphin-induced paralysis and loss of the tail-flick reflex.
Stewart P; Isaac L
Brain Res; 1991 Mar; 543(2):322-6. PubMed ID: 1676332
[TBL] [Abstract][Full Text] [Related]
2. Dynorphin A (1-13) potentiates dynorphin A (1-17) on loss of the tail-flick reflex after intrathecal injection in the rat.
Qu ZX; Isaac L
Brain Res; 1993 May; 610(2):340-3. PubMed ID: 8100473
[TBL] [Abstract][Full Text] [Related]
3. MK-801 blocks dynorphin A (1-13)-induced loss of the tail-flick reflex in the rat.
Isaac L; Van Zandt O'Malley T; Ristic H; Stewart P
Brain Res; 1990 Oct; 531(1-2):83-7. PubMed ID: 1981166
[TBL] [Abstract][Full Text] [Related]
4. Influence of dynorphin (1-13) on spinal reflexes in the rat.
Caudle RM; Isaac L
J Pharmacol Exp Ther; 1988 Aug; 246(2):508-13. PubMed ID: 2900326
[TBL] [Abstract][Full Text] [Related]
5. A novel interaction between dynorphin(1-13) and an N-methyl-D-aspartate site.
Caudle RM; Isaac L
Brain Res; 1988 Mar; 443(1-2):329-32. PubMed ID: 2896056
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal dynorphin(1-13) results in an irreversible loss of the tail-flick reflex in rats.
Caudle RM; Isaac L
Brain Res; 1987 Dec; 435(1-2):1-6. PubMed ID: 2892573
[TBL] [Abstract][Full Text] [Related]
7. Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis.
Bakshi R; Faden AI
Brain Res; 1990 Jan; 507(1):1-5. PubMed ID: 1967971
[TBL] [Abstract][Full Text] [Related]
8. Localization of dynorphin-induced neurotoxicity in rat spinal cord.
Stewart P; Isaac L
Life Sci; 1989; 44(20):1505-14. PubMed ID: 2566882
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats.
Xue JC; Yu YX; Han JS; Jen MF
Int J Neurosci; 1995 May; 82(1-2):83-93. PubMed ID: 7591518
[TBL] [Abstract][Full Text] [Related]
10. Antinociception and paralysis induced by intrathecal dynorphin A.
Herman BH; Goldstein A
J Pharmacol Exp Ther; 1985 Jan; 232(1):27-32. PubMed ID: 2856940
[TBL] [Abstract][Full Text] [Related]
11. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
Long JB; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between motor paralysis and neurotoxicity induced by intrathecal dynorphin A (1-17) in rats].
Cui CL; Wu LZ; Han JS
Yao Xue Xue Bao; 1997; 32(2):85-9. PubMed ID: 11243205
[TBL] [Abstract][Full Text] [Related]
13. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity.
Skilling SR; Sun X; Kurtz HJ; Larson AA
Brain Res; 1992 Mar; 575(2):272-8. PubMed ID: 1349253
[TBL] [Abstract][Full Text] [Related]
14. 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury.
Long JB; Skolnick P
Eur J Pharmacol; 1994 Aug; 261(3):295-301. PubMed ID: 7813551
[TBL] [Abstract][Full Text] [Related]
15. [Intrathecal co-administration of kappa opioid receptor agonists and NMDA receptor antagonists induces synergistic analgesia in rats].
Li FC; Sun XJ; Hu WH; Jen MF
Yao Xue Xue Bao; 1994; 29(12):881-6. PubMed ID: 7709739
[TBL] [Abstract][Full Text] [Related]
16. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord.
Ren MF; Lu CH; Han JS
Peptides; 1985; 6(6):1015-20. PubMed ID: 2871545
[TBL] [Abstract][Full Text] [Related]
17. Hindlimb paralytic effects of prodynorphin-derived peptides following spinal subarachnoid injection in rats.
Long JB; Martinez-Arizala A; Echevarria EE; Tidwell RE; Holaday JW
Eur J Pharmacol; 1988 Aug; 153(1):45-54. PubMed ID: 2905665
[TBL] [Abstract][Full Text] [Related]
18. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
Long JB; Petras JM; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
[TBL] [Abstract][Full Text] [Related]
19. Distinguishable effects of intrathecal dynorphins, somatostatin, neurotensin and s-calcitonin on nociception and motor function in the rat.
Spampinato S; Romualdi P; Candeletti S; Cavicchini E; Ferri S
Pain; 1988 Oct; 35(1):95-104. PubMed ID: 2904671
[TBL] [Abstract][Full Text] [Related]
20. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
Long JB; Rigamonti DD; de Costa B; Rice KC; Martinez-Arizala A
Brain Res; 1989 Sep; 497(1):155-62. PubMed ID: 2571391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
